These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24760152)

  • 1. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.
    Campbell IK; Miescher S; Branch DR; Mott PJ; Lazarus AH; Han D; Maraskovsky E; Zuercher AW; Neschadim A; Leontyev D; McKenzie BS; Käsermann F
    J Immunol; 2014 Jun; 192(11):5031-8. PubMed ID: 24760152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
    Leontyev D; Katsman Y; Ma XZ; Miescher S; Käsermann F; Branch DR
    Transfusion; 2012 Aug; 52(8):1799-805. PubMed ID: 22257295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer.
    Lewis BJB; Ville J; Blacquiere M; Cen S; Spirig R; Zuercher AW; Käsermann F; Branch DR
    BMC Immunol; 2019 Dec; 20(1):44. PubMed ID: 31801459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.
    Galeotti C; Stephen-Victor E; Karnam A; Das M; Gilardin L; Maddur MS; Wymann S; Vonarburg C; Chevailler A; Dimitrov JD; Benveniste O; Bruhns P; Kaveri SV; Bayry J
    J Allergy Clin Immunol; 2019 Aug; 144(2):524-535.e8. PubMed ID: 30529242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a receptor required for the anti-inflammatory activity of IVIG.
    Anthony RM; Wermeling F; Karlsson MC; Ravetch JV
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19571-8. PubMed ID: 19036920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
    Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin.
    Othy S; Topçu S; Saha C; Kothapalli P; Lacroix-Desmazes S; Käsermann F; Miescher S; Bayry J; Kaveri SV
    Eur J Immunol; 2014 Jul; 44(7):2059-63. PubMed ID: 24700174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation.
    Käsermann F; Boerema DJ; Rüegsegger M; Hofmann A; Wymann S; Zuercher AW; Miescher S
    PLoS One; 2012; 7(6):e37243. PubMed ID: 22675478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.
    Washburn N; Schwab I; Ortiz D; Bhatnagar N; Lansing JC; Medeiros A; Tyler S; Mekala D; Cochran E; Sarvaiya H; Garofalo K; Meccariello R; Meador JW; Rutitzky L; Schultes BC; Ling L; Avery W; Nimmerjahn F; Manning AM; Kaundinya GV; Bosques CJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1297-306. PubMed ID: 25733881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
    Issekutz AC; Rowter D; Miescher S; Käsermann F
    Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients.
    Sharma M; Schoindre Y; Hegde P; Saha C; Maddur MS; Stephen-Victor E; Gilardin L; Lecerf M; Bruneval P; Mouthon L; Benveniste O; Kaveri SV; Bayry J
    Sci Rep; 2014 Jul; 4():5672. PubMed ID: 25012067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.
    Anthony RM; Kobayashi T; Wermeling F; Ravetch JV
    Nature; 2011 Jun; 475(7354):110-3. PubMed ID: 21685887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.
    Anthony RM; Nimmerjahn F; Ashline DJ; Reinhold VN; Paulson JC; Ravetch JV
    Science; 2008 Apr; 320(5874):373-6. PubMed ID: 18420934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
    Schwab I; Biburger M; Krönke G; Schett G; Nimmerjahn F
    Eur J Immunol; 2012 Apr; 42(4):826-30. PubMed ID: 22278120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo.
    Schwab I; Mihai S; Seeling M; Kasperkiewicz M; Ludwig RJ; Nimmerjahn F
    Eur J Immunol; 2014 May; 44(5):1444-53. PubMed ID: 24505033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways.
    Murakami K; Suzuki C; Kobayashi F; Nakano A; Fujii A; Sakai K; Imada T
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Sep; 385(9):891-8. PubMed ID: 22644107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.
    Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN
    J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):87-8. PubMed ID: 25546774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy.
    Wong AH; Fukami Y; Sudo M; Kokubun N; Hamada S; Yuki N
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):275-9. PubMed ID: 25814494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
    Kaneko Y; Nimmerjahn F; Ravetch JV
    Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.